New rapid blood test could speed up heart attack diagnosis
NCT ID NCT06463275
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study measured troponin I levels in 1355 healthy adults to determine normal ranges for a new rapid test called SpinChip hs-cTnI. Troponin is a protein released during a heart attack, and having accurate normal values helps doctors diagnose heart attacks more reliably. The test uses a small cartridge and analyzer to give quick results from a blood sample.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
SpinChip hs-cTnI test (a diagnostic test using a cartridge and analyzer to measure troponin I in blood)
What this could lead to
If successful, this test could help doctors diagnose heart attacks faster and more accurately using a simple blood sample.
What could go wrong
This study only established normal reference ranges in healthy people; it did not test the test's ability to diagnose heart attacks in real patients. Further studies are needed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYOCARDIAL INFARCTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CTC Clinical Trial Consultants AB
Uppsala, Uppsala County, 752 37, Sweden
-
Clinical Trial Consultants (CTC) Ebbepark
Linköping, 58213, Sweden
-
Clinical Trial Consultants (CTC) GoCo
Mölndal, Gothenburg, 431 53, Sweden
-
Phase I-IV Research Unit Karolinska
Solna, 171 64, Sweden